Clinical Updates

A drug being developed by Intercept Pharmaceuticals Inc led to significant improvement in signs of a rare liver disease that… »   

Johnson & Johnson said on Friday it was ending its efforts to bring to market a rival drug to Allergan… »   

Texas is reconsidering whether to impose strict limits on Gilead Sciences’ $84,000 hepatitis C treatment for patients on the… »   

Prosecutors in Rome have opened an investigation into four executives at Swiss drugmakers Roche and Novartis on suspicion of fraud… »   

Anika Therapeutics Inc said the U.S. Food and Drug Administration approved its drug to treat pain and improve joint mobility… »   

Bristol-Myers Squibb Co said the U.S. Food and Drug Administration approved its drug to treat rare and potentially fatal… »   

Afatinib (trade name: GIOTRIF) has been approved in Germany since September 2013 for the treatment of adult patients with locally… »   

For the more than one million people with HIV/AIDS in the United States (and the over 34 million people… »   

The U.S. Food and Drug Administration said on Saturday certain lots of the supplement L-citrulline, used to treat genetic disorders… »   

The US Food and Drug Administration (FDA) announced that it will significantly restrict the use of the diabetes drug rosiglitazone… »   

Pharmaceutical group Roche said it secured an injunction from an Indian court banning generic drug makers Biocon and Mylan from… »   

The U.S. Food and Drug Administration has denied an appeal by Sprout Pharmaceuticals to approve its experimental drug for… »   

European regulators have recommended suspending a popular bone-building drug made by unlisted French firm Servier because of the risk of… »   

A treatment developed by Chelsea Therapeutics International Ltd for a rare type of low blood pressure is presenting problems for… »   

Regarding side effects, there are both positive and negative effects in comparison with beta interferon 1a

Teriflunomide (trade name: Aubagio)… »